Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC [Phase 2]
A Phase 2 trial evaluating anlotinib in combination with docetaxel for EGFR/ALK/ROS1 mutation-negative advanced nonsquamous non-small cell l…
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating afatinib and selumetinib in advanced KRAS mutant and PIK3CA wildtype non-small cell lung cancer is ong…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating QL1101 and Avastin in combination with paclitaxel and carboplatin as first-line therapy for non-squamous non-smal…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating safety and tolerability of cobimetinib plus GDC-0994 in patients with various advanced solid tumors, including no…
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Taxotere-Enoxaparin-(ENOXA)-Study [Phase 3]
Phase 3 trial of Taxotere in combination with enoxaparin for non-small cell lung cancer was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing the combination of ensartinib and durvalumab in ALK-rearranged non-small cell lung cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating adding demcizumab to carboplatin/pemetrexed in nonsquamous non-small cell lung cancer; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC [Phase 1, Phase 2]
Clinical trial update for anlotinib combined with chemotherapy as first-line treatment in advanced NSCLC (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial update on adaptive radiotherapy for non-small cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating Neoadjuvant Compound 121564 with platinum doublet chemotherapy in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer [Phase 2]
This Phase 2 safety and efficacy study evaluates nab-paclitaxel alone or in combination with CC-486 (azacitidine) or durvalumab in second/th…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours [Phase 3]
Phase 3 trial comparing osimertinib (AZD9291) plus durvalumab (MEDI4736) versus osimertinib alone in EGFR T790M-positive non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial update evaluating gemcitabine with radiation therapy or combination chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy [Phase 1]
This Phase 1 trial evaluated the combination of nintedanib and docetaxel in Japanese patients with the adenocarcinoma subtype of non-small c…
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC [Phase 2]
Phase 2 trial investigating atezolizumab monotherapy and subsequent therapy with atezolizumab plus bevacizumab for non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC [Phase 2]
Phase 2 trial exploring Endostar combined with radiotherapy for brain metastases stemming from non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects [Phase 1]
Phase 1 trial update evaluating BAT1706 (bevacizumab biosimilar) versus comparators in healthy subjects; non-small cell lung cancer is liste…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating azacitidine plus entinostat before chemotherapy in patients with advanced non-small cell lung cancer. The trial was…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Phase I Study of the Combination of Anlotinib With Gefitinib [NA]
This document provides an update on a Phase I trial evaluating the combination of Anlotinib and Gefitinib in non-squamous non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC [Phase 1, Phase 2]
A clinical trial update for SHR-1210 in combination with SHR6390 in patients with advanced colorectal cancer, non-small cell lung cancer, an…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating gemcitabine hydrochloride or pemetrexed disodium with carboplatin, with or without celecoxib, in patients with ad…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
A clinical trial evaluating genomic profiling in previously untreated metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: AUY922 in Patient With Stage IV NSCLC [Phase 2]
Completed Phase 2 clinical trial update of the HSP90 inhibitor luminespib (AUY922) in a patient with stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the combination of Anlotinib with chemotherapy regimens for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System [NA]
This terminated clinical trial evaluated stereotactic body radiation therapy for non-small cell lung cancer using 4D PET/CT with RPM, and co…